Filter
5285
Text search:
drug
access
Featured
Recommendations
472
New Publications
1401
Language
Document type
No document type
3144
Studies & Reports
888
Guidelines
633
Manuals
236
Strategic & Response Plan
177
Fact sheets
75
Training Material
68
Situation Updates
23
Infographics
16
Resource Platforms
12
Brochures
6
Online Courses
3
App
2
Videos
1
Countries / Regions
India
285
Global
188
Kenya
166
South Africa
140
Uganda
128
Ethiopia
120
Nigeria
115
Western and Central Europe
113
Tanzania
101
Nepal
90
Sierra Leone
87
Liberia
85
Malawi
85
Africa
85
Zambia
82
Myanmar / Burma
78
Latin America and the Carribbean
74
Bangladesh
69
Ghana
67
Rwanda
67
Eastern Europe
59
Namibia
56
Ukraine
55
Asia
44
Zimbabwe
43
Philippines
43
Cambodia
36
Lesotho
36
South–East Asia Region
36
Russia
27
Congo, Democratic Republic of
26
Botswana
26
Syria
24
Senegal
23
Indonesia
23
Mozambique
23
Burkina Faso
21
Eswatini/ Swaziland
19
East and Southern Africa
19
Cameroon
16
South Sudan
16
Brazil
16
Haiti
15
Colombia
15
West and Central Africa
15
Thailand
13
Eastern Europe and Central Asia
12
USA
11
Middle East and North Africa
11
Venezuela
11
Albania
11
Tajikistan
11
Guinea
10
Pakistan
10
China
10
Georgia
10
Vietnam
10
Afghanistan
9
Germany
9
Benin
9
Moldova
8
Sudan
7
Laos
7
North Macedonia
6
Mexico
6
Sri Lanka
6
Western Pacific Region
6
Armenia
6
North America
6
Mali
5
Iraq
5
Jordan
5
Lebanon
5
Central African Republic
5
Peru
5
Somalia
4
Turkey
4
Argentina
4
El Salvador
4
Libya
4
Yemen
4
Timor Leste/ East Timor
4
Iran
4
Jamaica
4
United Kingdom
4
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
Honduras
3
Bolivia
3
Madagascar
3
Bhutan
3
Palestine
3
Kyrgyzstan
3
Morocco
2
Saudi Arabia
2
Chad
2
Switzerland
2
Serbia
2
Hungary
2
Guatemala
2
Nicaragua
2
Chile
2
Poland
2
Southern Africa
2
Canada
2
Uzbekistan
2
Kazakhstan
2
Gabon
2
France
2
Portugal
2
Spain
2
Belarus
2
Niger
1
Egypt
1
Gambia
1
Ireland
1
Singapore
1
Dominican Republic
1
Ecuador
1
Greece
1
Paraguay
1
Fiji
1
North Korea
1
Italy
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Australia
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
2023
Clinical Guidelines
429
Public Health
247
Women & Child Health
205
Key Resources
157
Capacity Building
84
Pharmacy & Technologies
55
Annual Report MEDBOX
1
Toolboxes
HIV
705
Mental Health
486
TB
484
AMR
257
NTDs
202
COVID-19
196
Pharmacy
151
NCDs
106
Malaria
101
Caregiver
100
Ebola & Marburg
78
Planetary Health
69
Refugee
67
Disability
62
Conflict
62
Rapid Response
60
Global Health Education
59
Health Financing Toolbox
51
2.0 Rapid Response
25
Cholera
22
Polio
19
Natural Hazards
18
Zika
16
Specific Hazards
14
Social Ethics
13
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middl
...
Southern Med Review (2009)2;1:2-6
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
The European Journal of Public Health, Vol. 28, No. 1, 145–149
The Author 2017. Published by Oxford University Press on behalf of the European Public Health Association.
This is an Open Access article distributed under the terms of the Creativ
...
Revised Edition
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to thes
...
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordin
...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
HIV drug resistance strategies focus on prevention through adherence and treatment optimization, surveillance to monitor resistance trends, and innovation in new drugs and diagnostics. Key approaches include implementing national action plans, stren
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely
...
Policy Brief
Accessed: 20.11.2019
Research Article
Hindawi
BioMed Research International
Volume 2018, Article ID 9619684, 10 pages https://doi.org/10.1155/2018/9619684